Bloomberg
Insilico's Lung Drug Reverses Aging Markers in Study
Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)
View original source — Bloomberg ↗
Related stories
The Next Web
TechnologySep 7, 2026 · 1 min
Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial
The Next Web
Bloomberg
BusinessSep 7, 2026 · 1 min
AI-Discovered Drug Reverses Aging Markers in Study, Biotech Says
Bloomberg
The New York Times
TechnologySep 7, 2026 · 1 min
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
The New York Times
Nature
HealthJun 4, 2026 · 1 min
This mysterious lung disease affects millions of people — but a drug tested in mice shows promise
Nature